Population Health Management (PHM) Market by Component (Software, Services), Mode of Delivery (On-premise, Cloud-based), End User (Healthcare Providers (Hospitals, ACOs), Healthcare Payers, Employer Groups, Government Bodies) - Global Forecast to 2027
The global population health management market is projected to reach USD 53.3 billion by 2027 from USD 27.8 billion in 2022, at a CAGR of 13.9% during the forecast period. Growth in this market is driven by the growing government initiatives to improve community health, increasing patient pool, rising geriatric population and the growing need to curtail healthcare costs. However, lack of skilled IT professionals & high infrastructural investments are expected to restrain the growth of this market to a certain extent.
“The software segment is projected to be the largest segment& register the highest growth in the population health management market, by component”
Based on the component, the software segment is projected to be the largest segment& register the highest growth during the forecast period. Factors responsible for the growth of this segment is the increased adoption of software pertaining to improved operational efficiency, no upfront capital investment for hardware, enhanced patient engagement.
“Healthcare Providers was the largest segment by the end user of population health management market in 2021”
Healthcare providers segment is projected to grow at the highest growth rate in the population health management market in 2021. Growing need to curtail healthcare costs, rising need for better financial outcomes, ACA mandates is expected to drive the demand for population health management services in the coming years.
“APAC to witness the highest growth rate during the forecast period.”
The Asia Pacific market is projected to grow at the highest CAGR during the forecast period. Market growth in the APAC region is mainly driven by factors such as the improving healthcare infrastructure, growing medical tourism, government initiatives for the adoption of HCIT, increasing healthcare expenditure, and the rising purchasing power of consumers will also propel market growth.
The break-down of primary participants is as mentioned below:
The key players operating in the population health management market includeCerner Corporation (US), Epic Systems Corporation (US), Koninklijke Philips (Netherlands), i2i Population Health (US), Health Catalyst (US), Optum (US), Enli Health Intelligence (US), eClinicalWorks (US), Allscripts Healthcare Solutions (US), IBM Corporation (US), HealthEC LLC (US), Medecision (US), Arcadia (US), athenahealth (US), Cotiviti (US), NextGen Healthcare, Inc. (US), Conifer Health Solutions (US), SPH Analytics (US), Lightbeam Health Solutions (US), Innovaccer (US).
Research Coverage:
The report analyses the population health management market and aims to estimate the market size and future growth potential of various market segments, based on components, delivery mode, end user, and region. The report also provides a competitive analysis of the key players operating in this market, along with their company profiles, product offerings, recent developments, and key market strategies.
Reasons to Buy the Report
This report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share of the market. The report will help the leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall market and the sub-segments. This report will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market.
“The software segment is projected to be the largest segment& register the highest growth in the population health management market, by component”
Based on the component, the software segment is projected to be the largest segment& register the highest growth during the forecast period. Factors responsible for the growth of this segment is the increased adoption of software pertaining to improved operational efficiency, no upfront capital investment for hardware, enhanced patient engagement.
“Healthcare Providers was the largest segment by the end user of population health management market in 2021”
Healthcare providers segment is projected to grow at the highest growth rate in the population health management market in 2021. Growing need to curtail healthcare costs, rising need for better financial outcomes, ACA mandates is expected to drive the demand for population health management services in the coming years.
“APAC to witness the highest growth rate during the forecast period.”
The Asia Pacific market is projected to grow at the highest CAGR during the forecast period. Market growth in the APAC region is mainly driven by factors such as the improving healthcare infrastructure, growing medical tourism, government initiatives for the adoption of HCIT, increasing healthcare expenditure, and the rising purchasing power of consumers will also propel market growth.
The break-down of primary participants is as mentioned below:
- By Company Type - Tier 1:40%, Tier 2: 35%, and Tier 3: 25%
- By Designation - C-level: 25%, Director-level: 55%,and Others: 20%
- By Region - North America: 40%,Europe: 25%,AsiaPacific: 20%, Latin America: 10%,and Middle East & Africa: 5%.
The key players operating in the population health management market includeCerner Corporation (US), Epic Systems Corporation (US), Koninklijke Philips (Netherlands), i2i Population Health (US), Health Catalyst (US), Optum (US), Enli Health Intelligence (US), eClinicalWorks (US), Allscripts Healthcare Solutions (US), IBM Corporation (US), HealthEC LLC (US), Medecision (US), Arcadia (US), athenahealth (US), Cotiviti (US), NextGen Healthcare, Inc. (US), Conifer Health Solutions (US), SPH Analytics (US), Lightbeam Health Solutions (US), Innovaccer (US).
Research Coverage:
The report analyses the population health management market and aims to estimate the market size and future growth potential of various market segments, based on components, delivery mode, end user, and region. The report also provides a competitive analysis of the key players operating in this market, along with their company profiles, product offerings, recent developments, and key market strategies.
Reasons to Buy the Report
This report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share of the market. The report will help the leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall market and the sub-segments. This report will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market.
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.2.2 MARKETS COVERED
FIGURE 1 POPULATION HEALTH MANAGEMENT MARKET
FIGURE 2 REGIONAL SEGMENTS COVERED
1.2.3 YEARS CONSIDERED
1.3 CURRENCY CONSIDERED
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD
1.4 STAKEHOLDERS
1.5 LIMITATIONS
1.6 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 3 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
FIGURE 4 PRIMARY SOURCES
2.1.2.1 Key data from primary sources
2.1.2.2 Insights from primary experts
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY SIDE AND DEMAND SIDE PARTICIPANTS
FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
2.2.1 APPROACH 1: BOTTOM-UP APPROACH (DEMAND SIDE ANALYSIS)
FIGURE 7 BOTTOM-UP APPROACH (DEMAND SIDE ANALYSIS)
FIGURE 8 CAGR PROJECTIONS: SUPPLY SIDE ANALYSIS
2.2.2 APPROACH 2: TOP-DOWN APPROACH (SUPPLY SIDE ANALYSIS)
FIGURE 9 TOP-DOWN APPROACH
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 10 DATA TRIANGULATION METHODOLOGY
2.4 RESEARCH ASSUMPTIONS
2.5 RISK ASSESSMENT
TABLE 2 RISK ASSESSMENT: POPULATION HEALTH MANAGEMENT MARKET
3 EXECUTIVE SUMMARY
FIGURE 11 POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2022 VS. 2027 (USD MILLION)
FIGURE 12 POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2022 VS. 2027 (USD MILLION)
FIGURE 13 POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)
FIGURE 14 POPULATION HEALTH MANAGEMENT MARKET: GEOGRAPHICAL SNAPSHOT
4 PREMIUM INSIGHTS
4.1 POPULATION HEALTH MANAGEMENT MARKET OVERVIEW
FIGURE 15 NEED TO CURTAIL ESCALATING HEALTHCARE COSTS TO DRIVE MARKET
4.2 ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET, BY END USER AND COUNTRY (2021)
FIGURE 16 JAPAN DOMINATED ASIA PACIFIC MARKET IN 2021
4.3 POPULATION HEALTH MANAGEMENT MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 17 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
4.4 REGIONAL MIX: POPULATION HEALTH MANAGEMENT MARKET (2022?2027)
FIGURE 18 NORTH AMERICA TO DOMINATE GLOBAL MARKET DURING FORECAST PERIOD
4.5 POPULATION HEALTH MANAGEMENT MARKET: DEVELOPED VS. DEVELOPING MARKETS
FIGURE 19 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
TABLE 3 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES: IMPACT ANALYSIS
FIGURE 20 POPULATION HEALTH MANAGEMENT MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Government mandates and support for healthcare IT solutions
5.2.1.2 Need to curtail escalating healthcare costs
FIGURE 21 US HEALTHCARE SPENDING, 2012–2020 (USD BILLION)
5.2.1.3 Rising geriatric population and subsequent growth in chronic disease burden
5.2.2 RESTRAINTS
5.2.2.1 High investments in infrastructure to set up robust PHM program
5.2.2.2 Rising data breach concerns
5.2.3 OPPORTUNITIES
5.2.3.1 Growing importance of emerging markets in healthcare sector
5.2.3.2 Rising focus on personalized medicine
5.2.3.3 Increasing focus on value-based medicine
5.2.4 CHALLENGES
5.2.4.1 Lack of data management capabilities and skilled analysts
5.2.4.2 Interoperability issues
6 INDUSTRY INSIGHTS
6.1 INDUSTRY TRENDS
6.1.1 NEED FOR INTEROPERABILITY AND INTEGRATION TO DRIVE INNOVATION
6.1.2 SHIFT OF RISK BURDEN FROM PAYERS TO PROVIDERS
6.1.3 GROWING DEMAND FOR PATIENT-CENTRIC HEALTHCARE
FIGURE 22 VALUE-BASED CARE WORKFLOW
6.1.4 CLOUD-BASED IT SOLUTIONS
6.1.5 CONSOLIDATION OF HEALTHCARE PROVIDERS
6.2 ECOSYSTEM ANALYSIS
FIGURE 23 POPULATION HEALTH MANAGEMENT MARKET: ECOSYSTEM ANALYSIS
6.3 EVOLUTION OF ACOS: A PROMISING PAYMENT REFORM
6.3.1 INTRODUCTION
FIGURE 24 ACOS: REIMBURSEMENT MODEL
6.3.2 US: EVOLUTION OF ACOS
FIGURE 25 EVOLUTION OF ACO MODELS
6.3.3 ROLE OF INFORMATION TECHNOLOGY IN ACCOUNTABLE CARE
FIGURE 26 ACCOUNTABLE CARE SOLUTIONS AND THEIR USE
6.4 HCIT EXPENDITURE ANALYSIS
6.4.1 NORTH AMERICA
TABLE 4 NORTH AMERICA: HEALTHCARE EXPENDITURE, BY COUNTRY
6.4.2 EUROPE
6.4.3 ASIA PACIFIC
TABLE 5 JAPAN: HEALTHCARE IT INITIATIVES AND FUNDING
TABLE 6 CHINA: HEALTHCARE IT INITIATIVES AND FUNDING
6.5 REGULATORY ANALYSIS
6.5.1 NORTH AMERICA
6.5.2 EUROPE
6.5.3 ASIA PACIFIC
6.6 PORTER’S FIVE FORCES ANALYSIS
FIGURE 27 DEGREE OF COMPETITION TO BE HIGH IN POPULATION HEALTH MANAGEMENT MARKET
TABLE 7 POPULATION HEALTH MANAGEMENT MARKET: PORTER’S FIVE FORCES ANALYSIS
6.7 PATENT ANALYSIS
FIGURE 28 TOP PATENT OWNERS AND APPLICANTS FOR POPULATION HEALTH MANAGEMENT SOLUTIONS (JANUARY 2011–SEPTEMBER 2022)
FIGURE 29 PATENT ANALYSIS: POPULATION HEALTH MANAGEMENT MARKET (JANUARY 2017–SEPTEMBER 2022)
6.8 ADJACENT MARKET ANALYSIS
FIGURE 30 PATIENT REGISTRY SOFTWARE MARKET: MARKET OVERVIEW
FIGURE 31 AMBULATORY EHR MARKET: MARKET OVERVIEW
6.9 CASE STUDY
6.10 KEY STAKEHOLDERS AND BUYING CRITERIA
6.10.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 32 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS
TABLE 8 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR DEPLOYMENT MODES (%)
6.10.2 BUYING CRITERIA
FIGURE 33 KEY BUYING CRITERIA FOR DEPLOYMENT MODES
TABLE 9 KEY BUYING CRITERIA FOR DEPLOYMENT MODES
6.11 KEY CONFERENCES AND EVENTS (2022-2023)
6.12 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
FIGURE 34 REVENUE SHIFT IN POPULATION HEALTH MANAGEMENT MARKET
6.13 PRICING ANALYSIS
6.13.1 INITIAL FEES
TABLE 10 PRE-ELEMENT FEE FOR PHM SOLUTIONS
6.13.2 ANNUAL MAINTENANCE FEES
TABLE 11 ANNUAL MAINTENANCE FEE FOR PHM SOLUTIONS
6.14 TECHNOLOGY ANALYSIS
6.14.1 INTEGRATION OF AI AND ML
6.14.2 DATA ANALYTICS
7 POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT
7.1 INTRODUCTION
TABLE 12 POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
7.2 SOFTWARE
7.2.1 SOFTWARE TO DOMINATE COMPONENT SEGMENT
TABLE 13 POPULATION HEALTH MANAGEMENT SOFTWARE OFFERED BY KEY PLAYERS
TABLE 14 POPULATION HEALTH MANAGEMENT SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.3 SERVICES
7.3.1 INDISPENSABLE AND RECURRING NATURE OF SERVICES TO PROPEL MARKET
TABLE 15 POPULATION HEALTH MANAGEMENT SERVICES OFFERED BY KEY PLAYERS
TABLE 16 POPULATION HEALTH MANAGEMENT SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
8 POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY
8.1 INTRODUCTION
TABLE 17 POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020–2027 (USD MILLION)
8.2 ON-PREMISE MODE OF DELIVERY
8.2.1 TRADITIONAL ON-PREMISE DEPLOYMENT TO ALLOW TIME TO TEST SOFTWARE UPGRADES BEFORE IMPLEMENTATION
TABLE 18 ON-PREMISE MODE OF DELIVERY: PROS AND CONS
TABLE 19 POPULATION HEALTH MANAGEMENT MARKET FOR ON-PREMISE SOLUTIONS, BY COUNTRY, 2020–2027 (USD MILLION)
8.3 CLOUD-BASED MODE OF DELIVERY
8.3.1 CLOUD-BASED DELIVERY TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
TABLE 20 CLOUD-BASED MODE OF DELIVERY: PROS AND CONS
TABLE 21 POPULATION HEALTH MANAGEMENT MARKET FOR CLOUD-BASED SOLUTIONS, BY COUNTRY, 2020–2027 (USD MILLION)
9 POPULATION HEALTH MANAGEMENT MARKET, BY END USER
9.1 INTRODUCTION
TABLE 22 POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION)
9.2 HEALTHCARE PROVIDERS
9.2.1 NEED TO IMPROVE PROFITABILITY OF HEALTHCARE OPERATIONS TO BOOST MARKET
TABLE 23 POPULATION HEALTH MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY COUNTRY, 2020–2027 (USD MILLION)
9.3 HEALTHCARE PAYERS
9.3.1 INCREASED FOCUS ON OUTCOME-BASED PAYMENT MODELS TO STIMULATE DEMAND FOR PHM SOLUTIONS
TABLE 24 POPULATION HEALTH MANAGEMENT MARKET FOR HEALTHCARE PAYERS, BY COUNTRY, 2020–2027 (USD MILLION)
9.4 OTHER END USERS
TABLE 25 POPULATION HEALTH MANAGEMENT MARKET FOR OTHER END USERS, BY COUNTRY, 2020–2027 (USD MILLION)
10 POPULATION HEALTH MANAGEMENT MARKET, BY REGION
10.1 INTRODUCTION
TABLE 26 POPULATION HEALTH MANAGEMENT MARKET, BY REGION, 2020–2027 (USD MILLION)
10.2 NORTH AMERICA
FIGURE 35 NORTH AMERICA: POPULATION HEALTH MANAGEMENT MARKET SNAPSHOT
TABLE 27 NORTH AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 28 NORTH AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 29 NORTH AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020–2027 (USD MILLION)
TABLE 30 NORTH AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION)
10.2.1 US
10.2.1.1 US to dominate North American market during forecast period
TABLE 31 US: MACROECONOMIC INDICATORS
TABLE 32 US: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 33 US: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020–2027 (USD MILLION)
TABLE 34 US: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION)
10.2.2 CANADA
10.2.2.1 Deployment of digital health initiatives to boost market
TABLE 35 CANADA: MACROECONOMIC INDICATORS
TABLE 36 CANADA: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 37 CANADA: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020–2027 (USD MILLION)
TABLE 38 CANADA: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION)
10.3 EUROPE
TABLE 39 EUROPE: E-HEALTH PRIORITIES FOR HEALTHCARE PROVIDERS, BY COUNTRY, 2019
TABLE 40 EUROPE: POPULATION HEALTH MANAGEMENT MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 41 EUROPE: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 42 EUROPE: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020–2027 (USD MILLION)
TABLE 43 EUROPE: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION)
10.3.1 GERMANY
10.3.1.1 Germany to dominate European population health management market
TABLE 44 GERMANY: MACROECONOMIC INDICATORS
TABLE 45 GERMANY: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 46 GERMANY: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020–2027 (USD MILLION)
TABLE 47 GERMANY: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION)
10.3.2 UK
10.3.2.1 Increasing public-private initiatives to support adoption of PHM solutions
TABLE 48 UK: MACROECONOMIC INDICATORS
TABLE 49 UK: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 50 UK: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020–2027 (USD MILLION)
TABLE 51 UK: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION)
10.3.3 FRANCE
10.3.3.1 Increasing patient volume for chronic and age-related conditions to fuel market
TABLE 52 FRANCE: MACROECONOMIC INDICATORS
TABLE 53 FRANCE: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 54 FRANCE: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020–2027 (USD MILLION)
TABLE 55 FRANCE: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION)
10.3.4 ITALY
10.3.4.1 Government initiatives to support market
TABLE 56 ITALY: MACROECONOMIC INDICATORS
TABLE 57 ITALY: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 58 ITALY: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020–2027 (USD MILLION)
TABLE 59 ITALY: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION)
10.3.5 SPAIN
10.3.5.1 Demand for e-prescriptions and better patient record management to drive adoption of PHM solutions
TABLE 60 SPAIN: MACROECONOMIC INDICATORS
TABLE 61 SPAIN: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 62 SPAIN: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020–2027 (USD MILLION)
TABLE 63 SPAIN: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION)
10.3.6 REST OF EUROPE
TABLE 64 REST OF EUROPE: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 65 REST OF EUROPE: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020–2027 (USD MILLION)
TABLE 66 REST OF EUROPE: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION)
10.4 ASIA PACIFIC
FIGURE 36 ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET SNAPSHOT
TABLE 67 ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 68 ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 69 ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020–2027 (USD MILLION)
TABLE 70 ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION)
10.4.1 JAPAN
10.4.1.1 Japan accounted for largest share of Asia Pacific market in 2021
TABLE 71 JAPAN: MACROECONOMIC INDICATORS
TABLE 72 JAPAN: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 73 JAPAN: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020–2027 (USD MILLION)
TABLE 74 JAPAN: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION)
10.4.2 CHINA
10.4.2.1 Strong government support to propel market
TABLE 75 CHINA: MACROECONOMIC INDICATORS
TABLE 76 CHINA: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 77 CHINA: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020–2027 (USD MILLION)
TABLE 78 CHINA: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION)
10.4.3 INDIA
10.4.3.1 Growing volume of patient data generated within healthcare systems to drive market
TABLE 79 INDIA: MACROECONOMIC INDICATORS
TABLE 80 INDIA: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 81 INDIA: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020–2027 (USD MILLION)
TABLE 82 INDIA: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION)
10.4.4 REST OF ASIA PACIFIC
TABLE 83 REST OF ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 84 REST OF ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020–2027 (USD MILLION)
TABLE 85 REST OF ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION)
10.5 LATIN AMERICA
10.5.1 BRAZIL, ARGENTINA, AND MEXICO TO EMERGE AS POTENTIAL HEALTHCARE MARKETS
TABLE 86 LATIN AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 87 LATIN AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020–2027 (USD MILLION)
TABLE 88 LATIN AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION)
10.6 MIDDLE EAST & AFRICA
10.6.1 INCREASING INVESTMENTS IN MODERNIZING HEALTHCARE TO PROPEL MARKET
TABLE 89 MIDDLE EAST & AFRICA: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 90 MIDDLE EAST & AFRICA: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020–2027 (USD MILLION)
TABLE 91 MIDDLE EAST & AFRICA: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION)
11 COMPETITIVE LANDSCAPE
11.1 INTRODUCTION
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
FIGURE 37 KEY DEVELOPMENTS OF MAJOR PLAYERS BETWEEN JANUARY 2019 AND AUGUST 2022
11.3 POPULATION HEALTH MANAGEMENT MARKET: R&D EXPENDITURE
FIGURE 38 R&D EXPENDITURE OF KEY PLAYERS (2020 VS. 2021)
11.4 REVENUE ANALYSIS OF KEY PLAYERS
FIGURE 39 REVENUE ANALYSIS OF KEY PLAYERS (2021)
11.5 GEOGRAPHIC REVENUE ASSESSMENT OF KEY PLAYERS
FIGURE 40 POPULATION HEALTH MANAGEMENT MARKET: GEOGRAPHIC REVENUE MIX
11.6 COMPANY EVALUATION QUADRANT
11.6.1 STARS
11.6.2 EMERGING LEADERS
11.6.3 PERVASIVE PLAYERS
11.6.4 PARTICIPANTS
FIGURE 41 COMPETITIVE LEADERSHIP MAPPING, 2020
11.7 COMPETITIVE LEADERSHIP MAPPING – START-UPS/SMES
11.7.1 PROGRESSIVE COMPANIES
11.7.2 RESPONSIVE COMPANIES
11.7.3 DYNAMIC COMPANIES
11.7.4 STARTING BLOCKS
FIGURE 42 COMPETITIVE LEADERSHIP MAPPING FOR START-UPS/SMES
11.8 KEY PLAYERS ANALYSIS
TABLE 92 POPULATION HEALTH MANAGEMENT MARKET ANALYSIS, BY VENDOR TYPE
11.9 COMPETITIVE SITUATIONS AND TRENDS
11.9.1 PRODUCT LAUNCHES
11.9.2 DEALS
11.9.3 OTHER DEVELOPMENTS
12 COMPANY PROFILES
12.1 KEY PLAYERS
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1.1 CERNER CORPORATION
TABLE 93 CERNER CORPORATION: COMPANY OVERVIEW
FIGURE 43 CERNER CORPORATION: COMPANY SNAPSHOT (2021)
12.1.2 ALLSCRIPTS HEALTHCARE SOLUTIONS
TABLE 94 ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.: COMPANY OVERVIEW
FIGURE 44 ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.: COMPANY SNAPSHOT (2021)
12.1.3 IBM CORPORATION
TABLE 95 IBM CORPORATION: COMPANY OVERVIEW
FIGURE 45 IBM CORPORATION: COMPANY SNAPSHOT (2021)
12.1.4 EPIC SYSTEMS CORPORATION
TABLE 96 EPIC SYSTEMS CORPORATION: COMPANY OVERVIEW
12.1.5 KONINKLIJKE PHILIPS
TABLE 97 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW
FIGURE 46 PHILLIPS HEALTHCARE: COMPANY SNAPSHOT (2021)
12.1.6 I2I POPULATION HEALTH
TABLE 98 I2I POPULATION HEALTH: COMPANY OVERVIEW
12.1.7 HEALTH CATALYST
TABLE 99 HEALTH CATALYST: COMPANY OVERVIEW
FIGURE 47 HEALTH CATALYST: COMPANY SNAPSHOT (2021)
12.1.8 OPTUM INC. (A SUBSIDIARY OF UNITEDHEALTH GROUP)
TABLE 100 OPTUM, INC: COMPANY OVERVIEW
FIGURE 48 OPTUM: COMPANY SNAPSHOT (2021)
12.1.9 ENLI HEALTH INTELLIGENCE (A CEDAR GROUP TECHNOLOGIES)
TABLE 101 ENLI HEALTH INTELLIGENCE: COMPANY OVERVIEW
12.1.10 ECLINICALWORKS
TABLE 102 ECLINICALWORKS: COMPANY OVERVIEW
12.1.11 HEALTHEC, LLC
TABLE 103 HEALTHEC LLC: COMPANY OVERVIEW
12.1.12 MEDECISION
TABLE 104 MEDECISION: COMPANY OVERVIEW
12.1.13 ARCADIA
TABLE 105 ARCADIA: COMPANY OVERVIEW
12.1.14 ATHENAHEALTH
TABLE 106 ATHENAHEALTH, INC: COMPANY OVERVIEW
12.1.15 COTIVITI (VERSCEND TECHNOLOGIES)
TABLE 107 COTIVITI: COMPANY OVERVIEW
12.1.16 NEXTGEN HEALTHCARE, INC.
TABLE 108 NEXTGEN HEALTHCARE, INC.: COMPANY OVERVIEW
FIGURE 49 NEXTGEN HEALTHCARE: COMPANY SNAPSHOT (2021)
12.2 OTHER PLAYERS
12.2.1 CONIFER HEALTH SOLUTIONS
12.2.2 SPH ANALYTICS
12.2.3 LIGHTBEAM HEALTH SOLUTIONS
12.2.4 INNOVACCER
12.2.5 LUMERIS
12.2.6 ZEOMEGA
12.2.7 HGS HEALTHCARE, LLC
12.2.8 PERSIVIA
12.2.9 COLOR HEALTH, INC.
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
13 APPENDIX
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 AVAILABLE CUSTOMIZATIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.2.2 MARKETS COVERED
FIGURE 1 POPULATION HEALTH MANAGEMENT MARKET
FIGURE 2 REGIONAL SEGMENTS COVERED
1.2.3 YEARS CONSIDERED
1.3 CURRENCY CONSIDERED
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD
1.4 STAKEHOLDERS
1.5 LIMITATIONS
1.6 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 3 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
FIGURE 4 PRIMARY SOURCES
2.1.2.1 Key data from primary sources
2.1.2.2 Insights from primary experts
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY SIDE AND DEMAND SIDE PARTICIPANTS
FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
2.2.1 APPROACH 1: BOTTOM-UP APPROACH (DEMAND SIDE ANALYSIS)
FIGURE 7 BOTTOM-UP APPROACH (DEMAND SIDE ANALYSIS)
FIGURE 8 CAGR PROJECTIONS: SUPPLY SIDE ANALYSIS
2.2.2 APPROACH 2: TOP-DOWN APPROACH (SUPPLY SIDE ANALYSIS)
FIGURE 9 TOP-DOWN APPROACH
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 10 DATA TRIANGULATION METHODOLOGY
2.4 RESEARCH ASSUMPTIONS
2.5 RISK ASSESSMENT
TABLE 2 RISK ASSESSMENT: POPULATION HEALTH MANAGEMENT MARKET
3 EXECUTIVE SUMMARY
FIGURE 11 POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2022 VS. 2027 (USD MILLION)
FIGURE 12 POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2022 VS. 2027 (USD MILLION)
FIGURE 13 POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)
FIGURE 14 POPULATION HEALTH MANAGEMENT MARKET: GEOGRAPHICAL SNAPSHOT
4 PREMIUM INSIGHTS
4.1 POPULATION HEALTH MANAGEMENT MARKET OVERVIEW
FIGURE 15 NEED TO CURTAIL ESCALATING HEALTHCARE COSTS TO DRIVE MARKET
4.2 ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET, BY END USER AND COUNTRY (2021)
FIGURE 16 JAPAN DOMINATED ASIA PACIFIC MARKET IN 2021
4.3 POPULATION HEALTH MANAGEMENT MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 17 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
4.4 REGIONAL MIX: POPULATION HEALTH MANAGEMENT MARKET (2022?2027)
FIGURE 18 NORTH AMERICA TO DOMINATE GLOBAL MARKET DURING FORECAST PERIOD
4.5 POPULATION HEALTH MANAGEMENT MARKET: DEVELOPED VS. DEVELOPING MARKETS
FIGURE 19 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
TABLE 3 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES: IMPACT ANALYSIS
FIGURE 20 POPULATION HEALTH MANAGEMENT MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Government mandates and support for healthcare IT solutions
5.2.1.2 Need to curtail escalating healthcare costs
FIGURE 21 US HEALTHCARE SPENDING, 2012–2020 (USD BILLION)
5.2.1.3 Rising geriatric population and subsequent growth in chronic disease burden
5.2.2 RESTRAINTS
5.2.2.1 High investments in infrastructure to set up robust PHM program
5.2.2.2 Rising data breach concerns
5.2.3 OPPORTUNITIES
5.2.3.1 Growing importance of emerging markets in healthcare sector
5.2.3.2 Rising focus on personalized medicine
5.2.3.3 Increasing focus on value-based medicine
5.2.4 CHALLENGES
5.2.4.1 Lack of data management capabilities and skilled analysts
5.2.4.2 Interoperability issues
6 INDUSTRY INSIGHTS
6.1 INDUSTRY TRENDS
6.1.1 NEED FOR INTEROPERABILITY AND INTEGRATION TO DRIVE INNOVATION
6.1.2 SHIFT OF RISK BURDEN FROM PAYERS TO PROVIDERS
6.1.3 GROWING DEMAND FOR PATIENT-CENTRIC HEALTHCARE
FIGURE 22 VALUE-BASED CARE WORKFLOW
6.1.4 CLOUD-BASED IT SOLUTIONS
6.1.5 CONSOLIDATION OF HEALTHCARE PROVIDERS
6.2 ECOSYSTEM ANALYSIS
FIGURE 23 POPULATION HEALTH MANAGEMENT MARKET: ECOSYSTEM ANALYSIS
6.3 EVOLUTION OF ACOS: A PROMISING PAYMENT REFORM
6.3.1 INTRODUCTION
FIGURE 24 ACOS: REIMBURSEMENT MODEL
6.3.2 US: EVOLUTION OF ACOS
FIGURE 25 EVOLUTION OF ACO MODELS
6.3.3 ROLE OF INFORMATION TECHNOLOGY IN ACCOUNTABLE CARE
FIGURE 26 ACCOUNTABLE CARE SOLUTIONS AND THEIR USE
6.4 HCIT EXPENDITURE ANALYSIS
6.4.1 NORTH AMERICA
TABLE 4 NORTH AMERICA: HEALTHCARE EXPENDITURE, BY COUNTRY
6.4.2 EUROPE
6.4.3 ASIA PACIFIC
TABLE 5 JAPAN: HEALTHCARE IT INITIATIVES AND FUNDING
TABLE 6 CHINA: HEALTHCARE IT INITIATIVES AND FUNDING
6.5 REGULATORY ANALYSIS
6.5.1 NORTH AMERICA
6.5.2 EUROPE
6.5.3 ASIA PACIFIC
6.6 PORTER’S FIVE FORCES ANALYSIS
FIGURE 27 DEGREE OF COMPETITION TO BE HIGH IN POPULATION HEALTH MANAGEMENT MARKET
TABLE 7 POPULATION HEALTH MANAGEMENT MARKET: PORTER’S FIVE FORCES ANALYSIS
6.7 PATENT ANALYSIS
FIGURE 28 TOP PATENT OWNERS AND APPLICANTS FOR POPULATION HEALTH MANAGEMENT SOLUTIONS (JANUARY 2011–SEPTEMBER 2022)
FIGURE 29 PATENT ANALYSIS: POPULATION HEALTH MANAGEMENT MARKET (JANUARY 2017–SEPTEMBER 2022)
6.8 ADJACENT MARKET ANALYSIS
FIGURE 30 PATIENT REGISTRY SOFTWARE MARKET: MARKET OVERVIEW
FIGURE 31 AMBULATORY EHR MARKET: MARKET OVERVIEW
6.9 CASE STUDY
6.10 KEY STAKEHOLDERS AND BUYING CRITERIA
6.10.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 32 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS
TABLE 8 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR DEPLOYMENT MODES (%)
6.10.2 BUYING CRITERIA
FIGURE 33 KEY BUYING CRITERIA FOR DEPLOYMENT MODES
TABLE 9 KEY BUYING CRITERIA FOR DEPLOYMENT MODES
6.11 KEY CONFERENCES AND EVENTS (2022-2023)
6.12 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
FIGURE 34 REVENUE SHIFT IN POPULATION HEALTH MANAGEMENT MARKET
6.13 PRICING ANALYSIS
6.13.1 INITIAL FEES
TABLE 10 PRE-ELEMENT FEE FOR PHM SOLUTIONS
6.13.2 ANNUAL MAINTENANCE FEES
TABLE 11 ANNUAL MAINTENANCE FEE FOR PHM SOLUTIONS
6.14 TECHNOLOGY ANALYSIS
6.14.1 INTEGRATION OF AI AND ML
6.14.2 DATA ANALYTICS
7 POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT
7.1 INTRODUCTION
TABLE 12 POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
7.2 SOFTWARE
7.2.1 SOFTWARE TO DOMINATE COMPONENT SEGMENT
TABLE 13 POPULATION HEALTH MANAGEMENT SOFTWARE OFFERED BY KEY PLAYERS
TABLE 14 POPULATION HEALTH MANAGEMENT SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.3 SERVICES
7.3.1 INDISPENSABLE AND RECURRING NATURE OF SERVICES TO PROPEL MARKET
TABLE 15 POPULATION HEALTH MANAGEMENT SERVICES OFFERED BY KEY PLAYERS
TABLE 16 POPULATION HEALTH MANAGEMENT SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
8 POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY
8.1 INTRODUCTION
TABLE 17 POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020–2027 (USD MILLION)
8.2 ON-PREMISE MODE OF DELIVERY
8.2.1 TRADITIONAL ON-PREMISE DEPLOYMENT TO ALLOW TIME TO TEST SOFTWARE UPGRADES BEFORE IMPLEMENTATION
TABLE 18 ON-PREMISE MODE OF DELIVERY: PROS AND CONS
TABLE 19 POPULATION HEALTH MANAGEMENT MARKET FOR ON-PREMISE SOLUTIONS, BY COUNTRY, 2020–2027 (USD MILLION)
8.3 CLOUD-BASED MODE OF DELIVERY
8.3.1 CLOUD-BASED DELIVERY TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
TABLE 20 CLOUD-BASED MODE OF DELIVERY: PROS AND CONS
TABLE 21 POPULATION HEALTH MANAGEMENT MARKET FOR CLOUD-BASED SOLUTIONS, BY COUNTRY, 2020–2027 (USD MILLION)
9 POPULATION HEALTH MANAGEMENT MARKET, BY END USER
9.1 INTRODUCTION
TABLE 22 POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION)
9.2 HEALTHCARE PROVIDERS
9.2.1 NEED TO IMPROVE PROFITABILITY OF HEALTHCARE OPERATIONS TO BOOST MARKET
TABLE 23 POPULATION HEALTH MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY COUNTRY, 2020–2027 (USD MILLION)
9.3 HEALTHCARE PAYERS
9.3.1 INCREASED FOCUS ON OUTCOME-BASED PAYMENT MODELS TO STIMULATE DEMAND FOR PHM SOLUTIONS
TABLE 24 POPULATION HEALTH MANAGEMENT MARKET FOR HEALTHCARE PAYERS, BY COUNTRY, 2020–2027 (USD MILLION)
9.4 OTHER END USERS
TABLE 25 POPULATION HEALTH MANAGEMENT MARKET FOR OTHER END USERS, BY COUNTRY, 2020–2027 (USD MILLION)
10 POPULATION HEALTH MANAGEMENT MARKET, BY REGION
10.1 INTRODUCTION
TABLE 26 POPULATION HEALTH MANAGEMENT MARKET, BY REGION, 2020–2027 (USD MILLION)
10.2 NORTH AMERICA
FIGURE 35 NORTH AMERICA: POPULATION HEALTH MANAGEMENT MARKET SNAPSHOT
TABLE 27 NORTH AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 28 NORTH AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 29 NORTH AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020–2027 (USD MILLION)
TABLE 30 NORTH AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION)
10.2.1 US
10.2.1.1 US to dominate North American market during forecast period
TABLE 31 US: MACROECONOMIC INDICATORS
TABLE 32 US: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 33 US: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020–2027 (USD MILLION)
TABLE 34 US: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION)
10.2.2 CANADA
10.2.2.1 Deployment of digital health initiatives to boost market
TABLE 35 CANADA: MACROECONOMIC INDICATORS
TABLE 36 CANADA: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 37 CANADA: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020–2027 (USD MILLION)
TABLE 38 CANADA: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION)
10.3 EUROPE
TABLE 39 EUROPE: E-HEALTH PRIORITIES FOR HEALTHCARE PROVIDERS, BY COUNTRY, 2019
TABLE 40 EUROPE: POPULATION HEALTH MANAGEMENT MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 41 EUROPE: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 42 EUROPE: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020–2027 (USD MILLION)
TABLE 43 EUROPE: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION)
10.3.1 GERMANY
10.3.1.1 Germany to dominate European population health management market
TABLE 44 GERMANY: MACROECONOMIC INDICATORS
TABLE 45 GERMANY: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 46 GERMANY: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020–2027 (USD MILLION)
TABLE 47 GERMANY: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION)
10.3.2 UK
10.3.2.1 Increasing public-private initiatives to support adoption of PHM solutions
TABLE 48 UK: MACROECONOMIC INDICATORS
TABLE 49 UK: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 50 UK: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020–2027 (USD MILLION)
TABLE 51 UK: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION)
10.3.3 FRANCE
10.3.3.1 Increasing patient volume for chronic and age-related conditions to fuel market
TABLE 52 FRANCE: MACROECONOMIC INDICATORS
TABLE 53 FRANCE: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 54 FRANCE: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020–2027 (USD MILLION)
TABLE 55 FRANCE: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION)
10.3.4 ITALY
10.3.4.1 Government initiatives to support market
TABLE 56 ITALY: MACROECONOMIC INDICATORS
TABLE 57 ITALY: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 58 ITALY: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020–2027 (USD MILLION)
TABLE 59 ITALY: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION)
10.3.5 SPAIN
10.3.5.1 Demand for e-prescriptions and better patient record management to drive adoption of PHM solutions
TABLE 60 SPAIN: MACROECONOMIC INDICATORS
TABLE 61 SPAIN: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 62 SPAIN: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020–2027 (USD MILLION)
TABLE 63 SPAIN: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION)
10.3.6 REST OF EUROPE
TABLE 64 REST OF EUROPE: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 65 REST OF EUROPE: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020–2027 (USD MILLION)
TABLE 66 REST OF EUROPE: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION)
10.4 ASIA PACIFIC
FIGURE 36 ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET SNAPSHOT
TABLE 67 ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 68 ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 69 ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020–2027 (USD MILLION)
TABLE 70 ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION)
10.4.1 JAPAN
10.4.1.1 Japan accounted for largest share of Asia Pacific market in 2021
TABLE 71 JAPAN: MACROECONOMIC INDICATORS
TABLE 72 JAPAN: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 73 JAPAN: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020–2027 (USD MILLION)
TABLE 74 JAPAN: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION)
10.4.2 CHINA
10.4.2.1 Strong government support to propel market
TABLE 75 CHINA: MACROECONOMIC INDICATORS
TABLE 76 CHINA: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 77 CHINA: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020–2027 (USD MILLION)
TABLE 78 CHINA: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION)
10.4.3 INDIA
10.4.3.1 Growing volume of patient data generated within healthcare systems to drive market
TABLE 79 INDIA: MACROECONOMIC INDICATORS
TABLE 80 INDIA: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 81 INDIA: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020–2027 (USD MILLION)
TABLE 82 INDIA: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION)
10.4.4 REST OF ASIA PACIFIC
TABLE 83 REST OF ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 84 REST OF ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020–2027 (USD MILLION)
TABLE 85 REST OF ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION)
10.5 LATIN AMERICA
10.5.1 BRAZIL, ARGENTINA, AND MEXICO TO EMERGE AS POTENTIAL HEALTHCARE MARKETS
TABLE 86 LATIN AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 87 LATIN AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020–2027 (USD MILLION)
TABLE 88 LATIN AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION)
10.6 MIDDLE EAST & AFRICA
10.6.1 INCREASING INVESTMENTS IN MODERNIZING HEALTHCARE TO PROPEL MARKET
TABLE 89 MIDDLE EAST & AFRICA: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 90 MIDDLE EAST & AFRICA: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020–2027 (USD MILLION)
TABLE 91 MIDDLE EAST & AFRICA: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION)
11 COMPETITIVE LANDSCAPE
11.1 INTRODUCTION
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
FIGURE 37 KEY DEVELOPMENTS OF MAJOR PLAYERS BETWEEN JANUARY 2019 AND AUGUST 2022
11.3 POPULATION HEALTH MANAGEMENT MARKET: R&D EXPENDITURE
FIGURE 38 R&D EXPENDITURE OF KEY PLAYERS (2020 VS. 2021)
11.4 REVENUE ANALYSIS OF KEY PLAYERS
FIGURE 39 REVENUE ANALYSIS OF KEY PLAYERS (2021)
11.5 GEOGRAPHIC REVENUE ASSESSMENT OF KEY PLAYERS
FIGURE 40 POPULATION HEALTH MANAGEMENT MARKET: GEOGRAPHIC REVENUE MIX
11.6 COMPANY EVALUATION QUADRANT
11.6.1 STARS
11.6.2 EMERGING LEADERS
11.6.3 PERVASIVE PLAYERS
11.6.4 PARTICIPANTS
FIGURE 41 COMPETITIVE LEADERSHIP MAPPING, 2020
11.7 COMPETITIVE LEADERSHIP MAPPING – START-UPS/SMES
11.7.1 PROGRESSIVE COMPANIES
11.7.2 RESPONSIVE COMPANIES
11.7.3 DYNAMIC COMPANIES
11.7.4 STARTING BLOCKS
FIGURE 42 COMPETITIVE LEADERSHIP MAPPING FOR START-UPS/SMES
11.8 KEY PLAYERS ANALYSIS
TABLE 92 POPULATION HEALTH MANAGEMENT MARKET ANALYSIS, BY VENDOR TYPE
11.9 COMPETITIVE SITUATIONS AND TRENDS
11.9.1 PRODUCT LAUNCHES
11.9.2 DEALS
11.9.3 OTHER DEVELOPMENTS
12 COMPANY PROFILES
12.1 KEY PLAYERS
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1.1 CERNER CORPORATION
TABLE 93 CERNER CORPORATION: COMPANY OVERVIEW
FIGURE 43 CERNER CORPORATION: COMPANY SNAPSHOT (2021)
12.1.2 ALLSCRIPTS HEALTHCARE SOLUTIONS
TABLE 94 ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.: COMPANY OVERVIEW
FIGURE 44 ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.: COMPANY SNAPSHOT (2021)
12.1.3 IBM CORPORATION
TABLE 95 IBM CORPORATION: COMPANY OVERVIEW
FIGURE 45 IBM CORPORATION: COMPANY SNAPSHOT (2021)
12.1.4 EPIC SYSTEMS CORPORATION
TABLE 96 EPIC SYSTEMS CORPORATION: COMPANY OVERVIEW
12.1.5 KONINKLIJKE PHILIPS
TABLE 97 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW
FIGURE 46 PHILLIPS HEALTHCARE: COMPANY SNAPSHOT (2021)
12.1.6 I2I POPULATION HEALTH
TABLE 98 I2I POPULATION HEALTH: COMPANY OVERVIEW
12.1.7 HEALTH CATALYST
TABLE 99 HEALTH CATALYST: COMPANY OVERVIEW
FIGURE 47 HEALTH CATALYST: COMPANY SNAPSHOT (2021)
12.1.8 OPTUM INC. (A SUBSIDIARY OF UNITEDHEALTH GROUP)
TABLE 100 OPTUM, INC: COMPANY OVERVIEW
FIGURE 48 OPTUM: COMPANY SNAPSHOT (2021)
12.1.9 ENLI HEALTH INTELLIGENCE (A CEDAR GROUP TECHNOLOGIES)
TABLE 101 ENLI HEALTH INTELLIGENCE: COMPANY OVERVIEW
12.1.10 ECLINICALWORKS
TABLE 102 ECLINICALWORKS: COMPANY OVERVIEW
12.1.11 HEALTHEC, LLC
TABLE 103 HEALTHEC LLC: COMPANY OVERVIEW
12.1.12 MEDECISION
TABLE 104 MEDECISION: COMPANY OVERVIEW
12.1.13 ARCADIA
TABLE 105 ARCADIA: COMPANY OVERVIEW
12.1.14 ATHENAHEALTH
TABLE 106 ATHENAHEALTH, INC: COMPANY OVERVIEW
12.1.15 COTIVITI (VERSCEND TECHNOLOGIES)
TABLE 107 COTIVITI: COMPANY OVERVIEW
12.1.16 NEXTGEN HEALTHCARE, INC.
TABLE 108 NEXTGEN HEALTHCARE, INC.: COMPANY OVERVIEW
FIGURE 49 NEXTGEN HEALTHCARE: COMPANY SNAPSHOT (2021)
12.2 OTHER PLAYERS
12.2.1 CONIFER HEALTH SOLUTIONS
12.2.2 SPH ANALYTICS
12.2.3 LIGHTBEAM HEALTH SOLUTIONS
12.2.4 INNOVACCER
12.2.5 LUMERIS
12.2.6 ZEOMEGA
12.2.7 HGS HEALTHCARE, LLC
12.2.8 PERSIVIA
12.2.9 COLOR HEALTH, INC.
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
13 APPENDIX
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 AVAILABLE CUSTOMIZATIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS
